Farley J. Abad

Array ( [id] => 7221302 [patent_doc_number] => 20040072340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Use of peptide vectors to improve the immune response to antigens' [patent_app_type] => new [patent_app_number] => 10/270010 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6258 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072340.pdf [firstpage_image] =>[orig_patent_app_number] => 10270010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696369 [patent_doc_number] => 20030108563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Reagents for the simultaneous detection of HCV core antigens and antibodies' [patent_app_type] => new [patent_app_number] => 10/268562 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1478 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108563.pdf [firstpage_image] =>[orig_patent_app_number] => 10268562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6668364 [patent_doc_number] => 20030113347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them' [patent_app_type] => new [patent_app_number] => 10/269501 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10133 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20030113347.pdf [firstpage_image] =>[orig_patent_app_number] => 10269501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696733 [patent_doc_number] => 20030108927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases' [patent_app_type] => new [patent_app_number] => 10/265190 [patent_app_country] => US [patent_app_date] => 2002-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19798 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108927.pdf [firstpage_image] =>[orig_patent_app_number] => 10265190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642072 [patent_doc_number] => 20030103934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Drugs having long-term retention in target tissue' [patent_app_type] => new [patent_app_number] => 10/259773 [patent_app_country] => US [patent_app_date] => 2002-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8290 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103934.pdf [firstpage_image] =>[orig_patent_app_number] => 10259773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010233 [patent_doc_number] => 20050063949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Method of treating hepatitis virus infection with a multiphasic interferon delivery profile' [patent_app_type] => utility [patent_app_number] => 10/490458 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15733 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20050063949.pdf [firstpage_image] =>[orig_patent_app_number] => 10490458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692198 [patent_doc_number] => 20030039630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection' [patent_app_type] => new [patent_app_number] => 10/255442 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6317 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039630.pdf [firstpage_image] =>[orig_patent_app_number] => 10255442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683319 [patent_doc_number] => 20030119183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process' [patent_app_type] => new [patent_app_number] => 10/245037 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4704 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119183.pdf [firstpage_image] =>[orig_patent_app_number] => 10245037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116564 [patent_doc_number] => 20050069865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Synthetic hcv envelope proteins and their use for vaccination' [patent_app_type] => utility [patent_app_number] => 10/488269 [patent_app_country] => US [patent_app_date] => 2002-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5111 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069865.pdf [firstpage_image] =>[orig_patent_app_number] => 10488269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7024953 [patent_doc_number] => 20050019347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Recombinant mva capable of expressing structural hcv antigens' [patent_app_type] => utility [patent_app_number] => 10/488301 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12330 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20050019347.pdf [firstpage_image] =>[orig_patent_app_number] => 10488301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1046699 [patent_doc_number] => 06864093 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-08 [patent_title] => 'Method of identifying and treating invasive carcinomas' [patent_app_type] => utility [patent_app_number] => 10/235255 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 21 [patent_no_of_words] => 15117 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864093.pdf [firstpage_image] =>[orig_patent_app_number] => 10235255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684196 [patent_doc_number] => 20030120060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Human cytomegalovirus DNA constructs and uses therefor' [patent_app_type] => new [patent_app_number] => 10/223538 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 9786 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20030120060.pdf [firstpage_image] =>[orig_patent_app_number] => 10223538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6755333 [patent_doc_number] => 20030003110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Immunomodulatory effective compositions, methods for the production thereof and their use' [patent_app_type] => new [patent_app_number] => 10/218644 [patent_app_country] => US [patent_app_date] => 2002-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3325 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003110.pdf [firstpage_image] =>[orig_patent_app_number] => 10218644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829261 [patent_doc_number] => 20030180319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Antibacterial agents' [patent_app_type] => new [patent_app_number] => 10/215056 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6492 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180319.pdf [firstpage_image] =>[orig_patent_app_number] => 10215056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6842500 [patent_doc_number] => 20030147847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'ULBP DNA and polypeptides' [patent_app_type] => new [patent_app_number] => 10/212507 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 28758 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20030147847.pdf [firstpage_image] =>[orig_patent_app_number] => 10212507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6259766 [patent_doc_number] => 20020187466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Anticytomegalovirus monoclonal antibodies and processes for the in vitro diagnosis of infections by human cytomegaloviruses and a protein-kinase inducible by cytomegaloviruses and recognisable by aforesaid monoclonal antibodies' [patent_app_type] => new [patent_app_number] => 10/211356 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5374 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187466.pdf [firstpage_image] =>[orig_patent_app_number] => 10211356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931708 [patent_doc_number] => 20050282743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Molecular interactions in cells' [patent_app_type] => utility [patent_app_number] => 10/485788 [patent_app_country] => US [patent_app_date] => 2002-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 59876 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282743.pdf [firstpage_image] =>[orig_patent_app_number] => 10485788 [rel_patent_id] =>[rel_patent_doc_number] =>)